HomeConsent Form LibraryNuclear Medicine & Molecular ImagingRadioactive Iodine (I-131) Therapy Consent
Nuclear Medicine & Molecular Imaging Template Tool

Free Radioactive Iodine (I-131) Therapy Consent Consent Form Template

Operational & Compliance DisclaimerDisclaimer: This template is a sample for operational and administrative purposes only. ConsentCollect is a software platform, not a law firm or a healthcare provider. Consult with qualified legal counsel and medical directors to ensure compliance with local regulations before deploying any clinical consent form.
Professional medical consent form template for Radioactive Iodine (I-131) Therapy Consent
ConsentCollect Logo

Radioactive Iodine (I-131) Therapy Informed Consent

Patient Informed Consent Documentation

Patient and Facility Details

What is Radioactive Iodine Therapy?

Radioactive Iodine (I-131) is a specialized nuclear medicine treatment taken orally in liquid or capsule form. Thyroid cells absorb iodine naturally. When you swallow I-131, the radioactive iodine collects in your thyroid gland or remaining thyroid tissue, emitting radiation that safely destroys overactive thyroid cells or thyroid cancer cells without harming most other organs.

ABSOLUTE PREGNANCY AND BREASTFEEDING WARNING

CRITICAL CONTRAINDICATION: Radioactive Iodine (I-131) causes severe, permanent birth defects and destroys the fetal thyroid gland. I-131 therapy is strictly forbidden during pregnancy and breastfeeding. Female patients must complete a negative pregnancy test prior to administration and must discontinue breastfeeding completely before receiving treatment.

MANDATORY NRC 10 CFR 35.75 HOME RADIATION ISOLATION AGREEMENT

Potential Risks and Side Effects

Salivary Gland Swelling (Sialadenitis): Pain, dryness, or swelling in your cheeks and jaw due to radiation exposure to salivary glands.
Taste Changes: Temporary or long-term loss of taste or metallic taste in your mouth.
Neck Swelling or Soreness: Mild throat tightness or discomfort as thyroid tissue absorbs the dose.
Nausea or Stomach Upset: Mild digestive discomfort during the first 24 to 48 hours.
Permanent Hypothyroidism: Low thyroid hormone levels requiring lifelong daily thyroid hormone replacement pills.

Patient Acknowledgment and Authorization

I understand the purpose, pregnancy contraindications, salivary risks, and mandatory NRC home isolation protocols for I-131 therapy. I agree to follow all radiation safety instructions and consent to therapy.

Signatures

Document ID: CC-RADIOACTIVE-IODINE-THERAPY-CONSENT-FORM
POWERED BY CONSENTCOLLECT

Need to print or customize this template?

Download a clean PDF copy or customize it in our Free Consent Builder. No account required.

Looking for a complete clinical workflow?

Standard PDF consent forms still leave your practice exposed to malpractice disputes. If you want verified patient comprehension quizzes, automated signing order tracking, biometric signature seals, and direct Epic/Cerner EHR FHIR R4 integration, then upgrade to our full ConsentCollect App.

Free Document Schema Specifications

Template Classification:Radioactive Iodine (I-131) Therapy Consent Layout
Target File Format:Printable PDF / HTML Structure
Customization Capability:Fully Editable Text & Checklist Fields
Licensing & Rights:Free Personal & Practice-Wide Use

How to Use the Digital Radioactive Iodine (I-131) Therapy Consent Consent Template

The Radioactive Iodine (I-131) Therapy Consent document layout available on this page is a structured administrative schema designed for nuclear medicine & molecular imaging practice managers, compliance coordinators, and healthcare operations teams. Nuclear medicine therapy consent layout complying with NRC 10 CFR 35.75 release criteria. Outlines radioiodine treatment for hyperthyroidism and thyroid cancer, salivary gland risks, and mandatory home radiation isolation protocols.

Using the ConsentCollect Free Builder, administrative staff can import this radioactive iodine (i-131) therapy consent schema and configure every field to match their specific facility requirements. The builder supports drag-and-drop field reordering, custom label editing, signature block layout control, and client-side PDF generation, with no coding knowledge required and no account needed.

Once the radioactive iodine (i-131) therapy consent layout is finalized, it can be printed as a high-resolution paper document, embedded into a digital patient intake kiosk, or exported as a structured JSON payload for integration into an existing EHR or practice management system. Organizations running the full ConsentCollect App subscription gain access to verified comprehension tracking, automated signing sequence management, biometric signature seals, and FHIR R4 interoperability with Epic and Cerner platforms.

❓ Frequently Asked Questions

How do I import and configure this Radioactive Iodine (I-131) Therapy Consent document layout in the Free Builder?

Click the "Customize in Free Builder" button on this page. The form schema opens directly in the client-side ConsentCollect Free Builder canvas with all fields, sections, and signature blocks pre-loaded. You can then drag and drop additional fields, relabel any section header, swap placeholder text for your facility name and provider credentials, and rearrange the field order to match your clinic workflow, all without creating an account.

What document structure and field types does this Radioactive Iodine (I-131) Therapy Consent layout include?

This layout contains 7 structured sections covering patient identification fields, administrative intake data, acknowledgment checkboxes, and signature capture blocks. Practice managers and compliance officers can override any field label or placeholder value inside the builder to match their own intake schema.

Can I use this Radioactive Iodine (I-131) Therapy Consent template for my Nuclear Medicine & Molecular Imaging practice without a paid subscription?

Yes. The Free Advanced Form Builder is entirely public with no account required. You can open this radioactive iodine (i-131) therapy consent layout, edit all fields, and export a print-ready PDF or copy the underlying JSON schema at no cost. A paid ConsentCollect App subscription unlocks additional workflow features such as encrypted transmission, timestamped audit logs, multi-party signing order, and direct FHIR R4 EHR integrations.

Does this page provide clinical, legal, or medical advice about radioactive iodine (i-131) therapy consent procedures?

No. This page is an administrative document schema tool hosted by ConsentCollect, a B2B compliance software platform. The form layout is provided for operational and administrative configuration purposes only. ConsentCollect is not a law firm, healthcare provider, or clinical advisory service. Before deploying any consent document to patients, the finished form must be reviewed by your organization's qualified legal counsel and a licensed medical director to confirm compliance with applicable regulations in your jurisdiction.

How do I export, print, or integrate this Radioactive Iodine (I-131) Therapy Consent form schema into my EHR system?

After editing in the Free Builder, use the Export button to download a high-resolution PDF suitable for physical signature collection. Alternatively, copy the JSON schema payload for use in your own patient intake database or web application. Subscribers to the full ConsentCollect App can push finalized templates directly into Epic or Cerner workflows via a certified FHIR R4 integration layer without any manual re-entry.

How to Write a Radioactive Iodine (I-131) Therapy Consent Consent Form

Building a legally compliant and clinically sound consent document for radioactive iodine (i-131) therapy consent requires including specific structural components. Based on the pattern of this form, your final document should contain the following sections:

1

Patient and Facility Details

Establish a structured administrative block at the top of the document to record key identifying details. This includes fields for the patient's full name, date of birth, medical record number (MRN), the attending clinician or specialist, and the name of the facility or practice where the radioactive iodine (i-131) therapy consent will occur.

2

What is Radioactive Iodine Therapy?

Provide a clear, plain-language description explaining the nature and clinical purpose of the radioactive iodine (i-131) therapy consent procedure. Describe the steps involved in the process, the target areas of the body, and what the patient should expect during the course of the intervention.

3

ABSOLUTE PREGNANCY AND BREASTFEEDING WARNING

Outline your facility's financial policy, billing procedures, payment schedules, or study compensation terms, ensuring clear administrative boundaries and client responsibility.

4

MANDATORY NRC 10 CFR 35.75 HOME RADIATION ISOLATION AGREEMENT

Insert a formal patient declaration and authorization statement where the patient confirms they have read the document, understand the disclosures, had all their questions regarding radioactive iodine (i-131) therapy consent answered, and voluntarily authorize the procedure.

5

Potential Risks and Side Effects

Incorporate a dedicated risks section that lists the material risks and potential complications of radioactive iodine (i-131) therapy consent. It is critical to mention both common clinical complications (such as localized irritation, bleeding, or infection) and rarer, more severe risks (like nerve injury, systemic reactions, or long-term complications) to ensure informed decision-making.

6

Patient Acknowledgment and Authorization

Insert a formal patient declaration and authorization statement where the patient confirms they have read the document, understand the disclosures, had all their questions regarding radioactive iodine (i-131) therapy consent answered, and voluntarily authorize the procedure.

7

Signatures

Provide designated signature blocks for the patient (or legally authorized representative), the primary clinical provider, and an optional witness, including fields to capture the date, time, role declaration, and location or timestamp verification.

How to Collect Consent for Radioactive Iodine (I-131) Therapy Consent

To legally collect consent for a radioactive iodine (i-131) therapy consent procedure, you should use ConsentCollect. ConsentCollect is designed specifically for this clinical workflow by documenting radioactive iodine (I-131) therapy releases, pregnancy warnings, and home radiation isolation protocols. Utilizing ConsentCollect for your radioactive iodine (i-131) therapy consent consent forms ensures that your facility strictly complies with NRC 10 CFR 35.75 patient radiation release safety criteria.

Additionally, ConsentCollect's premium platform enforces multi-step radiation isolation acknowledgments for home distance and sanitation precautions. This removes the administrative burden of physical paper printouts and manual scanning while ensuring your nuclear medicine & molecular imaging patient intake is fully compliant, legally binding, and backed by robust clinical audit trails.